Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
JTO Clinical and Research Reports|November 19, 2025
Brief Report: Relationship Between Tumor Volume and Clinical Outcomes in Relapsed SCLCMatthew Lu, Hayden Byrd, Heidi Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆Megan L Hames, Heidi Chen, Wade Iams, et al.
Therapeutic Advances in Hematology|October 18, 2014
Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveWade Iams, Nishitha M Reddy
Journal of Hospital Medicine|May 19, 2015
Who is going to make the wise choice?David Leverenz, Wade Iams, Josh Heck, et al.
JTO Clinical and Research Reports|January 31, 2025
Brief Report: Impact of Maintenance Pemetrexed Cessation on Clinical Outcomes of Patients With Metastatic Nonsquamous NSCLCShreya Bhatia, Matthew Lu, Spencer Lessans, et al.
BMC Pulmonary Medicine|September 18, 2024
Potential for trans-pulmonary tumor markers in the early diagnosis of lung cancer: a case reportKen Monahan, Michael Kammer, Yan Ru Su, et al.
JAMA Facial Plastic Surgery|March 23, 2013
Full-thickness skin graft overlying a separately harvested auricular cartilage graft for nasal alar reconstructionDavid A Zopf, Wade Iams, Jennifer C Kim, et al.
Medical Oncology (Northwood, London, England)|April 9, 2013
Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case reportWade Iams, Kathyrn Eby Beckermann, Anne T Neff, et al.
Immunology|April 22, 2010
Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitisSaravanan Kanakasabai, Wanida Chearwae, Crystal C Walline, et al.
Journal for Immunotherapy of Cancer|May 18, 2018
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)Young Kwang Chae, Ayush Arya, Wade Iams, et al.
Pageof 23